Evidence map›Paper›PMID 25857745›Full record

ArticleNature communications2015

Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.

Sherin J Rouhani, Jacob D Eccles, Priscila Riccardi, J David Peske, Eric F Tewalt, Jarish N Cohen, Roland Liblau, Taija Mäkinen, Victor H Engelhard

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 133 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. From defense to disease: the multifaceted role of lymphatics during infection.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  9. Article
  10. An in-depth look at lung lymphatics.The Journal of experimental medicine · 2025
    Article
  11. Article
  12. Lymphatic transport in anti-tumor immunity and metastasis.The Journal of experimental medicine · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Lymphangiogenesis in gastric cancer: function and mechanism.European journal of medical research · 2023
    Review
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Sherin J RouhaniCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Jacob D EcclesCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Priscila RiccardiCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
J David PeskeCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Eric F TewaltCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Jarish N CohenCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Roland Liblau1] INSERM, Unité 1043, F-31300 Toulouse, France [2] Centre National de la Recherche Scientifique, Unité 5282, F-31300 Toulouse, France [3] Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse, Université Paul Sabatier, F-31300 Toulouse, France [4] Département d'Immunologie, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, F-31300 Toulouse, France.
Taija MäkinenDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Dag Hammarskjoldsv. 20, 751 85 Uppsala, Sweden.
Victor H EngelhardCarter Immunology Center, Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
University of Virginia · USInserm · FRUppsala University · SE

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigenR01AI068836 · NIAID · UNIVERSITY OF VIRGINIA · PI ENGELHARD, VICTOR H · 2007 to 2011
$2.1M
Lymphatic endothelial cells as inducers of systemic peripheral toleranceR21AI109250 · NIAID · UNIVERSITY OF VIRGINIA · PI ENGELHARD, VICTOR H · 2014 to 2015
$426k
Lymphatic endothelial cells as inducers of systemic peripheral toleranceR56AI099033 · NIAID · UNIVERSITY OF VIRGINIA · PI ENGELHARD, VICTOR H · 2013 to 2013
$260k
Cancer Research UKNCI NIH HHS 5 P30 CA044579NCI NIH HHS CA009109NCI NIH HHS P30 CA044579NCI NIH HHS T32 CA009109NIAID NIH HHS AI068836NIAID NIH HHS AI07496NIAID NIH HHS AI099033NIAID NIH HHS AI109250NIAID NIH HHS R01 AI068836NIAID NIH HHS R21 AI109250NIAID NIH HHS R56 AI099033NIAID NIH HHS T32 AI007496NIGMS NIH HHS GM007267NIGMS NIH HHS T32 GM007267
6 · The paper itself

Abstract

Lymphatic endothelial cells (LECs) directly express peripheral tissue antigens and induce CD8 T-cell deletional tolerance. LECs express MHC-II molecules, suggesting they might also tolerize CD4 T cells. We demonstrate that when β-galactosidase (β-gal) is expressed in LECs, β-gal-specific CD8 T cells undergo deletion via the PD-1/PD-L1 and LAG-3/MHC-II pathways. In contrast, LECs do not present endogenous β-gal in the context of MHC-II molecules to β-gal-specific CD4 T cells. Lack of presentation is independent of antigen localization, as membrane-bound haemagglutinin and I-Eα are also not presented by MHC-II molecules. LECs express invariant chain and cathepsin L, but not H2-M, suggesting that they cannot load endogenous antigenic peptides onto MHC-II molecules. Importantly, LECs transfer β-gal to dendritic cells, which subsequently present it to induce CD4 T-cell anergy. Therefore, LECs serve as an antigen reservoir for CD4 T-cell tolerance, and MHC-II molecules on LECs are used to induce CD8 T-cell tolerance via LAG-3.

Indexed as

AnimalsAntigen PresentationAntigensAntigens, CDAntigens, Differentiation, B-LymphocyteB7-H1 Antigenbeta-GalactosidaseBone Marrow CellsCathepsin LCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesClonal AnergyDendritic CellsEndothelial CellsGene ExpressionHemagglutininsAntigensAntigens, CDAntigens, Differentiation, B-LymphocyteB7-H1 Antigenbeta-GalactosidaseCathepsin LCd274 protein, mouseCTSL protein, humanHemagglutininsHistocompatibility Antigens Class III-E-antigeninvariant chainLag3 protein, mouseLymphocyte Activation Gene 3 ProteinPdcd1 protein, mouseProgrammed Cell Death 1 Receptor

Identifiers

PMID25857745
PMCPMC4403767
OpenAlexW1989831369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.